SAMRAT PHARMACHEM
Smallcap | BSE
Sector
Here's the live share price of Samrat Pharmachem along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.21₹ 4.85
As on Apr 17, 2026, 04:01 PM IST
Samrat Pharmachem Price Performance
Today's LowToday's High
₹220.00₹228.95
₹224.75
52 Weeks' Low52 Weeks' High
₹190.00₹425.00
₹224.75
Open Price
₹224.50
Prev. Close
₹219.90
Volume
1,942
Samrat Pharmachem Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Samrat Pharmachem | 8.08 | 4.22 | 1.51 | -24.36 | -37.63 | -25.71 | 9.1 |
| Sun Pharmaceutical Industries | 1.24 | -5.82 | 0.1 | -0.79 | -3.95 | 18.85 | 21.21 |
| Divi's Laboratories | 1.82 | 1.4 | 1.45 | -5.64 | 5.81 | 25.36 | 10.37 |
| Torrent Pharmaceuticals | 0.76 | -2.4 | 2.4 | 17.32 | 28.74 | 38.21 | 26.41 |
| Lupin | -0.48 | 0.82 | 6.57 | 19.37 | 15.56 | 52.24 | 16.94 |
| Dr. Reddy's Laboratories | 0.57 | -4.27 | 6.22 | -3.38 | 5.25 | 8.49 | 4.5 |
| Cipla | 0.71 | -2.36 | -10.99 | -24.46 | -18.07 | 10.94 | 5.52 |
| Zydus Lifesciences | 2.96 | 4.87 | 6.97 | -5.95 | 11.51 | 23.38 | 12.32 |
| Mankind Pharma | 2.18 | 1.03 | 0.29 | -13.44 | -17.79 | 14.26 | 8.32 |
| Aurobindo Pharma | 2.55 | 9.1 | 18.61 | 25.85 | 15.32 | 35.34 | 7.47 |
| Alkem Laboratories | 2.11 | 3.86 | -3.25 | -0.01 | 10.98 | 18.6 | 15.13 |
| Glenmark Pharmaceuticals | 3.81 | 2.69 | 12.79 | 21.18 | 64.01 | 66.08 | 31.14 |
| Laurus Labs | 3.38 | 15.46 | 6.82 | 23.28 | 77.27 | 55 | 20.83 |
| Biocon | 2.7 | -6.36 | -4.79 | -1.7 | 7.85 | 16.94 | -2.51 |
| Abbott India | 0.17 | -1.84 | -7.05 | -13.7 | -16.45 | 4.63 | 11.92 |
| GlaxoSmithKline Pharmaceuticals | 2.45 | 0.69 | 5.25 | -10.7 | -12.92 | 25.16 | 11.47 |
| Anthem Biosciences | -2.98 | 11.48 | 17.5 | -0.62 | -1.06 | -0.35 | -0.21 |
| Ipca Laboratories | 1.19 | -4.45 | -0.98 | 15.94 | 3.51 | 21.83 | 6.28 |
| Ajanta Pharma | -0.48 | -8.69 | 3.8 | 14.56 | 4.18 | 30.04 | 19.31 |
| J B Chemicals & Pharmaceuticals | -0.47 | -5.74 | 3.42 | 18.01 | 20.73 | 23.04 | 25.85 |
Over the last one year, Samrat Pharmachem has declined 37.63% compared to peers like Sun Pharmaceutical Industries (-3.95%), Divi's Laboratories (5.81%), Torrent Pharmaceuticals (28.74%). From a 5 year perspective, Samrat Pharmachem has underperformed peers relative to Sun Pharmaceutical Industries (21.21%) and Divi's Laboratories (10.37%).
Samrat Pharmachem Financials
Samrat Pharmachem Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 211.95 | 214.02 |
| 10 | 207.57 | 211.14 |
| 20 | 206.75 | 209.36 |
| 50 | 211.15 | 213.13 |
| 100 | 224.45 | 229.36 |
| 200 | 274.2 | 263.17 |
Samrat Pharmachem Share Holding Pattern
In the latest quarter, Samrat Pharmachem remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 3.24%, and public shareholding unchanged at 47.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Samrat Pharmachem Corporate Actions
Date Time | Announcement |
|---|---|
| Apr 07, 2026, 08:32 PM IST IST | Samrat Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 07, 2026, 08:11 PM IST IST | Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 30, 2026, 08:10 PM IST IST | Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Mar 25, 2026, 08:21 PM IST IST | Samrat Pharma - Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31, 2026 |
| Feb 13, 2026, 11:40 PM IST IST | Samrat Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held Today |
About Samrat Pharmachem
Samrat Pharmachem Ltd. is a Public Limited Listed company incorporated on 16/06/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1992PLC017820 and registration number is 017820. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 285.86 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No A2/3445, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Lalit MehtaChairman & Managing Director
- Mr. Rajesh MehtaExecutive Director & CFO
- Mr. Megh MehtaExecutive Director
- Ms. Renu DharodInd. Non-Executive Director
- Mr. Manishkumar PipaliaInd. Non-Executive Director
- Mr. Sachin KotharyInd. Non-Executive Director
- Ms. Megha JainInd. Non-Executive Director
FAQs on Samrat Pharmachem Share Price
What is the share price of Samrat Pharmachem?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Samrat Pharmachem is ₹224.75 as on Apr 17, 2026.
What kind of stock is Samrat Pharmachem?
The Samrat Pharmachem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Samrat Pharmachem?
The market cap of Samrat Pharmachem is ₹69.44 Cr as on Apr 17, 2026.
What are today's High and Low prices of Samrat Pharmachem?
Today’s highest and lowest price of Samrat Pharmachem are ₹228.95 and ₹220.00.
What are the 52 Week High and 52 Week Low of Samrat Pharmachem?
The 52-week high/low is the highest and lowest price at which Samrat Pharmachem stock has traded in the past 52-week or nearly a year. The 52-week high of Samrat Pharmachem is ₹425.00 and 52-week low of Samrat Pharmachem is ₹190.00 as on Apr 17, 2026.
How has the Samrat Pharmachem performed historically in terms of returns?
The Samrat Pharmachem has shown returns of 2.21% over the past day, 11.23% for the past month, 1.51% over 3 months, -34.06% over 1 year, -25.71% across 3 years, and 9.1% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Samrat Pharmachem?
P/E ratio of and PB ratio of Samrat Pharmachem are -41.47 and 0.99 on Apr 17, 2026. While the company gives a dividend yield of 0.44 per annum.
✕
Market Pulse